US and China Magnetic Nanoparticles Market Research Report Forecast to 2030

Magnetic nanoparticles are defined as the use of tiny particles that possess magnetic properties are typically ranging from 1 to 500 nanometers in size. Magnetic Nanoparticles are receptors immobilized magnetic nanoparticles bind specifically to bacteria and viruses. It is a core technology that can separate and concentrate target pathogens through magnetism. After directly synthesizing magnetic nanoparticles, self-coating is performed to prevent aggregation and then, various functional groups possessed are fixed to realize a concentrating effect. These nanoparticles are often composed of magnetic materials such as iron, cobalt, or nickel, or their alloys. They exhibit unique characteristics such as magnetic behavior at the nanoscale, which can be manipulated and controlled for various applications including electronics, healthcare sector, biomedical, energy and other applications. Magnetic nanoparticles have a wide range of uses in different fields due to their special properties. Most notably, magnetic nanoparticles are frequently employed in cancer treatment methods like magnetofection, photothermal therapy, photodynamic therapy, targeted drug delivery, and magnetic hyperthermia.

The US and China Magnetic Nanoparticles market is expected to be driven by increasing expansion of biomedical and healthcare sector in US and China. The Increase usage of magnetic nanoparticles technology in process of pretreatment kits are driving the US Magnetic Nanoparticles market.

However, the fluctuations in the prices of magnetic nanoparticles materials and toxicity and biocompatibility of magnetic nanoparticles materials will likely restrain market growth.

In China, there is a growing interest in the research and development of MNPs. The Chinese government has invested heavily in this market, and there are number of major MNP research projects underway in the country.

This report also provides an overview of the MNP research and development landscape in China. It discusses the major MNP research projects that are currently underway, and it provides an analysis of the spending on MNP research in China.

Market Segmentation

The functional group of magnetic particles has been majorly classified into -COOH, -NH2, -SiO2, -Tosyl, and Streptavidin. These functional groups employ to the surface of magnetic nanoparticles to provide specific properties and enable various interactions. Depending on the application, numerous functional groups can be employed on the surface of magnetic nanoparticles in magnetic separation and purification. The capacity of functional groups to preferentially attach to the target molecules or entities for separation or purification is often used to choose functional groups.

Major Players

Qiagen N. V., Bioneer Corporation, T2 Biosystems Inc., Thermo Fisher Scientific Inc., Hoffmann-La Roche Ltd., Creative Biogene, Baker Coulters Inc. (Danaher Corporation), MagBio Genomics Inc., DaAn Gene Co., Ltd, and MagGenome Technologies Pvt. Ltd among others are the major companies in the market.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

1.1 DEFINITION
1.2 SCOPE OF THE STUDY
1.3 RESEARCH OBJECTIVE
1.4 MARKET STRUCTURE
1.5 LIST OF ASSUMPTIONS

2 MARKET DYNAMICS

2.1 OVERVIEW
2.2 DRIVERS
- 2.2.1 EXPANSION OF BIOMEDICAL AND HEALTHCARE SECTOR IN US
- 2.2.2 EXPANSION OF BIOMEDICAL AND HEALTHCARE SECTOR IN CHINA
- 2.2.3 INCREASE USAGE OF MAGNETIC NANOPARTICLES TECHNOLOGY IN PRETREATMENT KITS
2.3 RESTRAINTS
- 2.3.1 FLUCTUATIONS IN THE PRICES OF MAGNETIC NANOPARTICLES MATERIALS IN CHINA
- 2.3.2 FLUCTUATIONS IN THE PRICES OF MAGNETIC NANOPARTICLES MATERIALS IN US
- 2.3.3 TOXICITY AND BIOCOMPATIBILITY OF MAGNETIC NANOPARTICLES MATERIALS
2.4 TRENDS
- 2.4.1 CORE TECHNOLOGY OF MAGNETIC NANOPARTICLES THAT CAN SEPARATE AND CONCENTRATE TARGET PATHOGENS THROUGH MAGNETISM
- 2.4.2 NANODIAGNOSTIC TECHNOLOGIES FOR SEPSIS USING MAGNETIC NANOPARTICLES (MNPS)
2.5 INCREASING RESEARCH & DEVELOPMENT ACTIVITY OF MAGNETIC NANOPARTICLE IN CHINA
2.6 MAGNETIC NANOPARTICLES (MNPS) RESEARCH PROJECTS IN THE US
- 2.6.1 MAGFORCE MRGFUS RESEARCH PROJECT
- 2.6.2 NANOSPHERE LNP-DOX RESEARCH PROJECT
- 2.6.3 CATALYSTS FOR SUSTAINABLE CHEMISTRY
- 2.6.4 ENVIRONMENTAL REMEDIATION
2.7 MAJOR DRAWBACKS OF MAGNETIC NANOPARTICLES

3 QUALITATIVE ANALYSIS ON FUNCTIONAL GROUP AND SIZE FOR MAGNETIC NANOPARTICLES

3.1 BY FUNCTIONAL GROUP
3.2 BY SIZE
3.3 OVERVIEW OF MAGNETIC BEAD-BASED METHOD EMPLOYED IN BIO-DIAGNOSTICS

4 US & CHINA MARKET SIZE FOR MAGNETIC NANOPARTICLES BY COUNTRY (USD MILLION)

5 COMPETITIVE LANDSCAPE

5.1 INTRODUCTION
5.2 COMPETITIVE ANALYSIS
5.3 MARKET SHARE ANALYSIS
5.4 MAJOR GROWTH STRATEGY IN THE MAGNETIC NANOPARTICES MARKET (BIO-DIAGNOSTIC END USERS)
5.5 COMPETITIVE BENCHMARKING
5.6 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN MAGNETIC NANOPARTICLES MARKET
5.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 5.7.1 PRODUCT LAUNCH/ PRODUCT DEVELOPMENT
- 5.7.2 PARTNERSHIP/COLLABORATION
5.8 MAJOR PLAYER FINANCIAL*
- 5.8.1 SALES, OPERATING INCOME, R&D EXPENDITURE 2022*

6 COMPANY PROFILES

6.1 QIAGEN NV
- 6.1.1 COMPANY OVERVIEW
- 6.1.2 FINANCIAL OVERVIEW
- 6.1.3 PRODUCTS OFFERED
- 6.1.4 KEY DEVELOPMENTS
- 6.1.5 SWOT ANALYSIS
- 6.1.6 KEY STRATEGIES
6.2 BIONEER CORPORATION
- 6.2.1 COMPANY OVERVIEW
- 6.2.2 FINANCIAL OVERVIEW
- 6.2.3 PRODUCTS OFFERED
- 6.2.4 KEY DEVELOPMENTS
- 6.2.5 SWOT ANALYSIS
- 6.2.6 KEY STRATEGIES
6.3 T2 BIOSYSTEMS, INC.
- 6.3.1 COMPANY OVERVIEW
- 6.3.2 FINANCIAL OVERVIEW
- 6.3.3 PRODUCTS OFFERED
- 6.3.4 KEY DEVELOPMENTS
- 6.3.5 SWOT ANALYSIS
- 6.3.6 KEY STRATEGIES
6.4 THERMO FISHER SCIENTIFIC INC.
- 6.4.1 COMPANY OVERVIEW
- 6.4.2 FINANCIAL OVERVIEW
- 6.4.3 PRODUCTS OFFERED
- 6.4.4 KEY DEVELOPMENTS
- 6.4.5 SWOT ANALYSIS
- 6.4.6 KEY STRATEGIES
6.5 HOFFMANN-LA ROCHE LTD
- 6.5.1 FINANCIAL OVERVIEW
- 6.5.2 PRODUCTS OFFERED
- 6.5.3 KEY DEVELOPMENTS
- 6.5.4 SWOT ANALYSIS
- 6.5.5 KEY STRATEGIES
6.6 CREATIVE BIOGENE
- 6.6.1 COMPANY OVERVIEW
- 6.6.2 FINANCIAL OVERVIEW
- 6.6.3 PRODUCTS OFFERED
- 6.6.4 KEY DEVELOPMENTS
- 6.6.5 SWOT ANALYSIS
- 6.6.6 KEY STRATEGIES
6.7 MAGGENOME TECHNOLOGIES PVT. LTD.
- 6.7.1 COMPANY OVERVIEW
- 6.7.2 FINANCIAL OVERVIEW
- 6.7.3 PRODUCTS OFFERED
- 6.7.4 KEY DEVELOPMENTS
- 6.7.5 SWOT ANALYSIS
- 6.7.6 KEY STRATEGIES
6.8 DAAN GENE CO., LTD.
- 6.8.1 COMPANY OVERVIEW
- 6.8.2 FINANCIAL OVERVIEW
- 6.8.3 PRODUCTS OFFERED
- 6.8.4 KEY DEVELOPMENTS
- 6.8.5 SWOT ANALYSIS
- 6.8.6 KEY STRATEGIES
6.9 MAGBIO GENOMICS INC.
- 6.9.1 COMPANY OVERVIEW
- 6.9.2 FINANCIAL OVERVIEW
- 6.9.3 PRODUCTS OFFERED
- 6.9.4 KEY DEVELOPMENTS
- 6.9.5 SWOT ANALYSIS
- 6.9.6 KEY STRATEGIES
6.10 BECKMAN COULTER INC. (DANAHER CORPORATION)
- 6.10.1 COMPANY OVERVIEW
- 6.10.2 FINANCIAL OVERVIEW
- 6.10.3 PRODUCTS OFFERED
- 6.10.4 KEY DEVELOPMENTS
- 6.10.5 SWOT ANALYSIS
- 6.10.6 KEY STRATEGIES
6.11 XI'AN TIANLONG SCIENCE AND TECHNOLOGY CO., LTD
- 6.11.1 COMPANY OVERVIEW
- 6.11.2 FINANCIAL OVERVIEW
- 6.11.3 PRODUCTS OFFERED
- 6.11.4 KEY DEVELOPMENTS
- 6.11.5 SWOT ANALYSIS
- 6.11.6 KEY STRATEGIES
6.12 GUANGZHOU DONGSHENG BIOTECH CO., LTD
- 6.12.1 COMPANY OVERVIEW
- 6.12.2 FINANCIAL OVERVIEW
- 6.12.3 PRODUCTS OFFERED
- 6.12.4 KEY DEVELOPMENTS
- 6.12.5 SWOT ANALYSIS
- 6.12.6 KEY STRATEGIES
6.13 GENEAID BIOTECH LTD.
- 6.13.1 COMPANY OVERVIEW
- 6.13.2 FINANCIAL OVERVIEW
- 6.13.3 PRODUCTS OFFERED
- 6.13.4 KEY DEVELOPMENTS
- 6.13.5 SWOT ANALYSIS
- 6.13.6 KEY STRATEGIES
6.14 TIANGEN BIOTECH(BEIJING)CO., LTD.
- 6.14.1 COMPANY OVERVIEW
- 6.14.2 FINANCIAL OVERVIEW
- 6.14.3 PRODUCTS OFFERED
- 6.14.4 KEY DEVELOPMENTS
- 6.14.5 SWOT ANALYSIS
- 6.14.6 KEY STRATEGIES
6.15 WUXI NEST BIOTECHNOLOGY CO., LTD
- 6.15.1 COMPANY OVERVIEW
- 6.15.2 FINANCIAL OVERVIEW
- 6.15.3 PRODUCTS OFFERED
- 6.15.4 KEY DEVELOPMENTS
- 6.15.5 SWOT ANALYSIS
- 6.15.6 KEY STRATEGIES

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS 14
TABLE 2 US & CHINA MARKET SIZE FOR MAGNETIC NANOPARTICLES BY COUNTRY (USD MILLION) 45
TABLE 3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT 52
TABLE 4 PARTNERSHIP/COLLABORATION 53
TABLE 5 SALES, OPERATING INCOME, R & D EXPENDITURE 2022 54
TABLE 6 QIAGEN N.V.: PRODUCTS OFFERED 57
TABLE 7 QIAGEN N. V.: KEY DEVELOPMENTS 58
TABLE 8 BIONEER CORPORATION: PRODUCTS OFFERED 61
TABLE 9 BIONEER CORPORATION: KEY DEVELOPMENTS 62
TABLE 10 T2 BIOSYSTEMS, INC.: PRODUCTS OFFERED 65
TABLE 11 T2 BIOSYSTEMS, INC.: KEY DEVELOPMENTS 65
TABLE 12 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 69
TABLE 13 HOFFMANN-LA ROCHE LTD: PRODUCTS OFFERED 73
TABLE 14 CREATIVE BIOGENE: PRODUCTS OFFERED 76
TABLE 15 MAGGENOME TECHNOLOGIES PVT. LTD.: PRODUCTS OFFERED 79
TABLE 16 MAGGENOME TECHNOLOGIES PVT. LTD.: KEY DEVELOPMENTS 80
TABLE 17 DAAN GENE CO., LTD: PRODUCTS OFFERED 83
TABLE 18 MAGBIO GENOMICS INC.: PRODUCTS OFFERED 86
TABLE 19 BECKMAN COULTER INC. (DANAHER CORPORATION): PRODUCTS OFFERED 90
TABLE 20 BECKMAN COULTER INC. (DANAHER CORPORATION): KEY DEVELOPMENTS 90
TABLE 21 XI'AN TIANLONG SCIENCE AND TECHNOLOGY CO., LTD: PRODUCTS OFFERED 93
TABLE 22 GUANGZHOU DONGSHENG BIOTECH CO., LTD: PRODUCTS OFFERED 97
TABLE 23 GENEAID BOITECH LTD.: PRODUCTS OFFERED 100
TABLE 24 GENEAID BOITECH LTD.: KEY DEVELOPMENTS 100
TABLE 25 TIANGEN BIOTECH (BEIJING) CO., LTD.: PRODUCTS OFFERED 104
TABLE 26 WUXI NEST BIOTECHNOLOGY CO., LTD.: PRODUCTS OFFERED 107

LIST OF FIGURES

FIGURE 1 MAGNETIC NANOPARTICLES MARKET: MARKET STRUCTURE 13
FIGURE 2 MARKET DYNAMICS: US AND CHINA MAGNETIC NANOPARTICLES MARKET 15
FIGURE 3 MARKET SIZE OF BIOMEDICAL INDUSTRY IN CHINA FROM 2015 TO 2019 (BILLION YUAN) 18
FIGURE 4 USE OF MNPS FOR BIOMEDICAL APPLICATIONS 19
FIGURE 5 SCHEMATIC PROCEDURE FOR NUCLEIC ACID PURIFICATION BY MEANS OF MAGNETIC NANOPARTICLE (MNPS) 21
FIGURE 6 DRIVERS: IMPACT ANALYSIS 22
FIGURE 7 PRICES FOR IRON ORE MARKET IN CHINA, 2019-2022, USD PER TONS 23
FIGURE 8 PRICES FOR IRON ORE MARKET IN US, 2019-2022, USD PER TONS 25
FIGURE 9 RESTRAINT: IMPACT ANALYSIS 27
FIGURE 10 RESTRAINT: IMPACT ANALYSIS 28
FIGURE 11 NANODIAGNOSTIC TECHNOLOGIES FOR SEPSIS USING MAGNETIC NANOPARTICLES (MNPS) 30
FIGURE 12

FIGURE A) REPRESENTS SCHEMATIC REPRESENTATION OF T2MR DIAGNOSTIC PLATFORM 31

FIGURE 13

FIGURE B) REPRESENTS NANOMAGNETO-DNA ASSAY FOR THE DETECTION OF BACTERIAL 16S RRNA 32

FIGURE 14

FIGURE C) REPRESENTS SERS SUBSTRATES TO ANCHOR ANTIBODY-DECORATED 33

FIGURE 15 MRI-GUIDED FOCUSED ULTRASOUND (MRGFUS) 35
FIGURE 16 CATALYSTS FOR SUSTAINABLE CHEMISTRY 36
FIGURE 17 MARKET SHARE ANALYSIS, 2022 48
FIGURE 18 COMPETITIVE BENCHMARKING 49
FIGURE 19 COMPETITIVE BENCHMARKING 50
FIGURE 20 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN MAGNETIC NANOPARTICLES MARKET (BIO-DIAGNOSTIC COMPANIES) 51
FIGURE 21 QIAGEN N. V.: FINANCIAL OVERVIEW SNAPSHOT 56
FIGURE 24 T2 BIOSYSTEMS, INC.: FINANCIAL OVERVIEW SNAPSHOT 64
FIGURE 26 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT 68
FIGURE 28 HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT 72
FIGURE 31 MAGGENOME TECHNOLOGIES PVT. LTD.: SWOT ANALYSIS 80
FIGURE 32 DAAN GENE CO., LTD: SWOT ANALYSIS 84
FIGURE 34 BECKMAN COULTER INC. (DANAHER CORPORATION): FINANCIAL OVERVIEW SNAPSHOT 89
FIGURE 35 BECKMAN COULTER INC. (DANAHER CORPORATION): SWOT ANALYSIS 91